Clinical Outcomes and Intrinsic Subtypes of Breast Cancer Patients with Single Hormone Receptor-positive Receiving Neoadjuvant Chemotherapy
CONCLUSION: This study highlighted the distinct clinical and genetic characteristics of sHR+ BRCA, emphasizing the potential need for optimized treatment strategies.PMID:38503615 | DOI:10.1016/j.clbc.2024.02.016
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Tingting Wang Jinnan Wang Wei Zhao Yueyin Pan Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Genetics | HER2 | Hormones | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study